259 related articles for article (PubMed ID: 12487823)
1. Rapid disease progression in human immunodeficiency virus type 1-infected seroconverters in India.
Mehendale SM; Bollinger RC; Kulkarni SS; Stallings RY; Brookmeyer RS; Kulkarni SV; Divekar AD; Gangakhedkar RR; Joshi SN; Risbud AR; Thakar MA; Mahajan BA; Kale VA; Ghate MV; Gadkari DA; Quinn TC; Paranjape RS
AIDS Res Hum Retroviruses; 2002 Nov; 18(16):1175-9. PubMed ID: 12487823
[TBL] [Abstract][Full Text] [Related]
2. Initial plasma HIV-1 RNA levels and progression to AIDS in women and men.
Sterling TR; Vlahov D; Astemborski J; Hoover DR; Margolick JB; Quinn TC
N Engl J Med; 2001 Mar; 344(10):720-5. PubMed ID: 11236775
[TBL] [Abstract][Full Text] [Related]
3. Viral dynamics and CD4+ T cell counts in subtype C human immunodeficiency virus type 1-infected individuals from southern Africa.
Gray CM; Williamson C; Bredell H; Puren A; Xia X; Filter R; Zijenah L; Cao H; Morris L; Vardas E; Colvin M; Gray G; McIntyre J; Musonda R; Allen S; Katzenstein D; Mbizo M; Kumwenda N; Taha T; Karim SA; Flores J; Sheppard HW
AIDS Res Hum Retroviruses; 2005 Apr; 21(4):285-91. PubMed ID: 15943570
[TBL] [Abstract][Full Text] [Related]
4. Predictors of virological outcome and safety in primary HIV type 1-infected patients initiating quadruple antiretroviral therapy: QUEST GW PROB3005.
Hoen B; Cooper DA; Lampe FC; Perrin L; Clumeck N; Phillips AN; Goh LE; Lindback S; Sereni D; Gazzard B; Montaner J; Stellbrink HJ; Lazzarin A; Ponscarme D; Staszewski S; Mathiesen L; Smith D; Finlayson R; Weber R; Wegmann L; Janossy G; Kinloch-de Loes S;
Clin Infect Dis; 2007 Aug; 45(3):381-90. PubMed ID: 17599319
[TBL] [Abstract][Full Text] [Related]
5. Immunological and virological responses to highly active antiretroviral therapy in a non-clinical trial setting in a developing Caribbean country.
Kilaru KR; Kumar A; Sippy N; Carter AO; Roach TC
HIV Med; 2006 Mar; 7(2):99-104. PubMed ID: 16420254
[TBL] [Abstract][Full Text] [Related]
6. HIV-1 viral rebound dynamics after a single treatment interruption depends on time of initiation of highly active antiretroviral therapy.
Steingrover R; Pogány K; Fernandez Garcia E; Jurriaans S; Brinkman K; Schuitemaker H; Miedema F; Lange JM; Prins JM
AIDS; 2008 Aug; 22(13):1583-8. PubMed ID: 18670217
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection.
Musey L; Hughes J; Schacker T; Shea T; Corey L; McElrath MJ
N Engl J Med; 1997 Oct; 337(18):1267-74. PubMed ID: 9345075
[TBL] [Abstract][Full Text] [Related]
8. A multicenter observational study of the potential benefits of initiating combination antiretroviral therapy during acute HIV infection.
Hecht FM; Wang L; Collier A; Little S; Markowitz M; Margolick J; Kilby JM; Daar E; Conway B; Holte S;
J Infect Dis; 2006 Sep; 194(6):725-33. PubMed ID: 16941337
[TBL] [Abstract][Full Text] [Related]
9. No change in viral set point or CD4 cell decline among antiretroviral treatment-naïve, HIV-1-infected individuals enrolled in the Danish HIV Cohort Study in 1995-2010.
Helleberg M; Kronborg G; Larsen CS; Pedersen G; Pedersen C; Obel N; Gerstoft J
HIV Med; 2013 Jul; 14(6):362-9. PubMed ID: 23433434
[TBL] [Abstract][Full Text] [Related]
10. Plasma viral load in HIV-1 and HIV-2 singly and dually infected individuals in Guinea-Bissau, West Africa: significantly lower plasma virus set point in HIV-2 infection than in HIV-1 infection.
Andersson S; Norrgren H; da Silva Z; Biague A; Bamba S; Kwok S; Christopherson C; Biberfeld G; Albert J
Arch Intern Med; 2000 Nov; 160(21):3286-93. PubMed ID: 11088091
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of X4 tropic viruses in patients recently infected with HIV-1 and lack of association with transmission of drug resistance.
de Mendoza C; Rodriguez C; García F; Eiros JM; Ruíz L; Caballero E; Aguilera A; Leiva P; Colomina J; Gutierrez F; del Romero J; Aguero J; Soriano V;
J Antimicrob Chemother; 2007 Apr; 59(4):698-704. PubMed ID: 17327295
[TBL] [Abstract][Full Text] [Related]
12. Human immunodeficiency virus type-1 (HIV-1) disease progression and viral activity: a seroepidemiological and molecular study.
Bukhari SZ; Qazi JI; Ashshi AM; Zia N
J Coll Physicians Surg Pak; 2012 Sep; 22(9):565-9. PubMed ID: 22980609
[TBL] [Abstract][Full Text] [Related]
13. [Consensus document of Gesida and Spanish Secretariat for the National Plan on AIDS (SPNS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)].
Panel de expertos de Gesida y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2012 Jun; 30(6):e1-89. PubMed ID: 22633764
[TBL] [Abstract][Full Text] [Related]
14. HIV-1 viral load and CD4 cell count in untreated children with vertically acquired asymptomatic or mild disease. Paediatric European Network for Treatment of AIDS (PENTA).
AIDS; 1998 Mar; 12(4):F1-8. PubMed ID: 9520161
[TBL] [Abstract][Full Text] [Related]
15. Natural history and risk factors associated with early and established HIV type 1 infection among reproductive-age women in Malawi.
Kumwenda JJ; Makanani B; Taulo F; Nkhoma C; Kafulafula G; Li Q; Kumwenda N; Taha TE
Clin Infect Dis; 2008 Jun; 46(12):1913-20. PubMed ID: 18462100
[TBL] [Abstract][Full Text] [Related]
16. Extended antiretroviral treatment interruption in HIV-infected patients with long-term suppression of plasma HIV RNA.
Achenbach CJ; Till M; Palella FJ; Knoll MD; Terp SM; Kalnins AU; Murphy RL
HIV Med; 2005 Jan; 6(1):7-12. PubMed ID: 15670246
[TBL] [Abstract][Full Text] [Related]
17. Estimation of the predictive role of plasma viral load on CD4 decline in HIV-1 subtype C-infected subjects in India.
Ding M; Tarwater P; Rodriguez M; Chatterjee R; Ratner D; Yamamura Y; Roy P; Mellors J; Neogi D; Chen Y; Gupta P
J Acquir Immune Defic Syndr; 2009 Feb; 50(2):119-25. PubMed ID: 19131898
[TBL] [Abstract][Full Text] [Related]
18. Loss of correlation between HIV viral load and CD4+ T-cell counts in HIV/HTLV-1 co-infection in treatment naive Mozambican patients.
Bhatt NB; Gudo ES; Semá C; Bila D; Di Mattei P; Augusto O; Garsia R; Jani IV
Int J STD AIDS; 2009 Dec; 20(12):863-8. PubMed ID: 19948902
[TBL] [Abstract][Full Text] [Related]
19. Reverse transcriptase activity for quantitation of HIV-1 subtype C in plasma: relation to RNA copy number and CD4 T-cell count.
Seyoum E; Wolday D; Girma M; Malmsten A; Meselle T; Gronowitz JS; Britton S
J Med Virol; 2006 Feb; 78(2):161-8. PubMed ID: 16372295
[TBL] [Abstract][Full Text] [Related]
20. Predictive value of plasma HIV RNA level on rate of CD4 T-cell decline in untreated HIV infection.
Rodríguez B; Sethi AK; Cheruvu VK; Mackay W; Bosch RJ; Kitahata M; Boswell SL; Mathews WC; Bangsberg DR; Martin J; Whalen CC; Sieg S; Yadavalli S; Deeks SG; Lederman MM
JAMA; 2006 Sep; 296(12):1498-506. PubMed ID: 17003398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
